Savings while ON TREATMENT
Eligible patients pay
as little as
for JYNARQUE® (tolvaptan)*
of all patients pay $10 or less per month for JYNARQUE, regardless of coverage type†
of patients with commercial insurance
have coverage‡
Since a REMS-certified Specialty Pharmacy will deliver JYNARQUE directly to your door, you do not need a copay card. Make sure to tell your Specialty Pharmacy that you are interested in having your copay support applied directly to lowering your out-of-pocket costs.
Get helpful texts and emails to support conversations with your healthcare team.
Speak one-on-one with someone living with ADPKD over the phone or on a video call.
Sign up for an interactive patient-led webinar to engage with other patients and caregivers.
ADPKD=autosomal dominant polycystic kidney disease; REMS=Risk Evaluation and Mitigation Strategy.
*Assumes one 28-day supply prescription per month. If more than one prescription is filled in a calendar month, you may pay more than $10 in that month. Offer is not transferable. Patients are not eligible if they are under 18 years of age or are covered in whole or in part by any state program or federal healthcare program, including, but not limited to, Medicare or Medicaid (including Medicaid managed care), Medigap, VA, DOD, or TRICARE. Patients must have a prescription consistent with FDA-approved product labeling for JYNARQUE. Only valid in US and Puerto Rico. Offer void where prohibited by law, taxed, or restricted. Other restrictions may apply. This program is not health insurance. Otsuka America Pharmaceutical, Inc. has the right to rescind, revoke, or amend this program at any time without notice. Your participation in this program confirms that this offer is consistent with your insurance coverage and that you will report the value received if required by your insurance provider. When you use this program, you are certifying that you understand and comply with the program rules, terms, and conditions. The information provided in this communication is provided for informational purposes and does not guarantee coverage or payment (partial or full). Actual benefits are determined by each plan’s administrator in accordance with its respective policy and procedures. Providers should consult with their payers for all relevant coverage, coding, and reimbursement requirements. It is the sole responsibility of the provider to ensure the accuracy of all claims used in seeking reimbursement. Nothing herein may be construed as an endorsement, approval, recommendation, representation, or warranty of any kind by any plan or insurer referenced. This communication is solely the responsibility of Otsuka America Pharmaceutical, Inc. This resource is not intended as legal advice or a substitute for a provider’s independent professional judgment.
†Managed Markets Insight & Technology, LLC: Analytics website as of June 21, 2022. Commercial lives exclude Health Insurance Exchanges Program (HIX) data.
‡Managed Markets Insight & Technology, LLC database as of July 2023.